Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 17 clinical trials
Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

sporadic small vessel diseases (SVDs) and in 30 patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

  • 08 Oct, 2020
  • 5 locations
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

This study will be the first to evaluate the role played by potential precipitating factors and risk factors in Reversible Cerebral Vasoconstriction Syndrome (RCVS) through of prospective selection of carefully characterised patients and controls. The impact of these factors on the prognosis will be evaluated through a follow-up assessment of …

  • 24 Jan, 2021
  • 1 location
Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty

Dysfunctions such as tight stenosis or thrombosis in haemodialysis vascular accesses are the leading cause of hospitalisationand morbidity in chronic haemodialysis patients incurring significant related costs estimated at over one billion dollars in the USA. Dysfunctions of these vascular accesses are generally treated by conventional angioplasty as this is the …

  • 22 Jan, 2021
  • 11 locations
ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.

Aim of the ACTION-1 study is to determine whether ACT guided heparinization decreases thrombo-embolic complications (TEC) and mortality after elective open AAA surgery, without causing more bleeding complications.

open repair
aaa surgery
aneurysm repair
aortic aneurysm
  • 17 Jan, 2021
  • 18 locations
Arteriopathy and Endothelial Function

To determine whether fruit juice might reverse endothelial dysfunction and whether this reversibility has a prognosis value

  • 07 Nov, 2020
  • 1 location
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A Plan)

Acute Aortic Syndrome (AAS) is a common feature of acute aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Increased levels of the inflammatory biomarker high-sensitivity …

  • 15 Jan, 2021
  • 1 location
Effect of a Neuromuscular Electrical Stimulation Program on Walking Capacity in Peripheral Artery Disease Patients

Lower extremity peripheral arterial disease (LEPAD) is a highly prevalent chronic disease. Cardiovascular mortality of LEPAD patients at five years ranges between 18 to 30%. LEPAD is primarily caused by atherosclerosis that induces an inadequate blood flow to meet the tissues demand due to the narrowing of the arteries. An …

  • 12 Jan, 2021
  • 12 locations
Platelets Induced Vasodilation in Vitro and in Vivo Study

interaction platelets/vessels. The effects of 7 days of each treatment will be compared in healthy subjects and patients with arteriopathy.

  • 07 Nov, 2020
  • 1 location
Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent

The laser-excimer technology could be an essential tool to correct the under-expansion of the stent once it has been implanted unless severe calcification. The laser-excimer technology achieves a greater minimum luminal area when treating an infra-expanded stent, when compared with the results obtained with the simple dilatation at high or …

  • 24 Dec, 2020
  • 4 locations
The PROMISE II Trial Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

The LimFlow System is intended for endovascular, minimally invasive procedures in patients who have a clinical diagnosis of chronic limb-threatening ischemia and who have been determined to have no surgical or endovascular treatment option (i.e., "no option").

limb ischemia
glycosylated hemoglobin
hemoglobin a1c
medication regimen
  • 03 Jan, 2021
  • 18 locations